tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market
NURPF
Neuren Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see NURPF full AI Analyst Report?

Neuren Pharmaceuticals Limited (NURPF) Stock News & Sentiment

55 Followers
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
Premium
Company Announcements
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
12d ago
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
Premium
Company Announcements
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
12d ago
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
Premium
Company Announcements
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
12d ago
Neuren details 2025 progress and governance in latest annual report
Premium
Company Announcements
Neuren details 2025 progress and governance in latest annual report
12d ago
Neuren Updates Market on Ongoing On‑Market Share Buy‑Back
Premium
Company Announcements
Neuren Updates Market on Ongoing On‑Market Share Buy‑Back
15d ago
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
16d ago
Neuren Updates Market on Progress of On-Market Share Buy-Back
Premium
Company Announcements
Neuren Updates Market on Progress of On-Market Share Buy-Back
19d ago
More NURPF News >

NURPF News on the Web

Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
TipRanks News
Neutral
Neuren Cancels Shares Following On-Market Buy-Back
TipRanks News
Neutral
Morgans names seven ASX healthcare stocks with upcoming catalysts
StockHead
Neutral
Is this battered ASX biotech stock ready to rocket higher?
The Motley Fool
Neutral
Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off
The Motley Fool
Neutral
Neuren Expands Rett Syndrome Reach as DAYBUE STIX Goes Broadly U.S.-Available
TipRanks News
Bullish
Biocurious: Battered local biotech valuations provide golden opportunities
StockHead
Neutral
Health Check: The biotech winners and losers from a messy March of mayhem
StockHead
Neutral

News Score - Last 7 Days

Neutral
NURPF
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NURPF’s Media Buzz Sentiment?
1 articles about NURPF were published this week. In an average week, 2.25 articles are published.
    What is NURPF’s weekly average amount of articles?
    In an average week, 2.25 articles about NURPF are published.
      What is NURPF’s News Sentiment?
      50% of articles about NURPF were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week